Israel: No association found between BCG vaccination and coronavirus infection
Studying adults aged 35 and 41 years who have received BCG vaccine and those who have not received it during
Read More
Clinical trial
Coronavirus: Inactivated PiCoVacc vaccine found safe, efficacious in animal study
Inactivated novel coronavirus vaccine (PiCoVacc) tested on mice, rats and rhesus macaques was found to be safe, and provided partial
Read More
Phase-2 trial: A three-drug regimen clears coronavirus in seven days
A phase-2 trial found that COVID-19 patients with mild to moderate illness had no detectable virus seven days after treatment
Read More
Explained: Being ready with Oxford University vaccine before trial ends
Serum Institute of India, Pune, will start manufacturing the vaccine the moment the Phase-3 trial begins. The company is confident
Read More
Coronavirus: Phase-1 human trial of Oxford University vaccine to begin today
The Oxford University team that uses a recombinant viral vector vaccine that uses a chimpanzee adenovirus vaccine vector (ChAdOx1) that
Read More
Coronavirus: Randomised, control trial shows hydroxychloroquine does not reduce viral load
Results of a randomised, control trial using hydroxychloroquine drug in 150 COVID-19 patients show that the drug does not reduce
Read More
Hydroxychloroquine study: Publisher expresses ‘concerns’ about the paper
The journal that published a paper claiming that hydroxychloroquine had “significant” success in treating COVID-19 patients now has an expression
Read More
CHIM: Infecting healthy people with coronavirus can speed up vaccine trials
While conventional human clinical trials of novel coronavirus vaccine will take 12-18 months to complete, the human challenge studies can
Read More
The vaccine was rapidly synthesised as novel coronavirus sequence was available: Gagandeep Kang
Moderna’s mRNA-1273 is the first vaccine for novel coronavirus (SARS-CoV-2) to enter human trials. This is a novel lipid nanoparticle-encapsulated
Read More
‘Serum’s pneumococcal vaccine will be available by June 2020’
Serum Institute is optimistic that its pneumococcal vaccine will be available in India by June 2020. The vaccine is yet
Read More
WHO prequalifies Serum’s low-cost pneumococcal vaccine
WHO has prequalified Pune-based Serum Institute’s pneumococcal conjugate vaccine made of 10 serotypes that are widely prevalent and cause pneumonia
Read MoreDeadly Ebola virus on the brink of being tamed
Preliminary analysis of 499 Ebola infected participants has sprung a surprise — the chances of survival may be as high
Read More
‘Unethical to withhold bedaquiline treatment while waiting for Phase III results’
In a Phase IIb trail, bedaquiline drug for MDR-TB treatment was found to be cardiotoxic and hepatotoxic, and it also
Read More